Women's Health Regulatory & Innovation Advisory

The Work

Women's health is not one regulatory category. A single brand can span prescription and OTC drugs, medical devices, dietary supplements, diagnostics, and digital tools, often within the same therapeutic area: menopause, fertility, pelvic health, hormone support, breast health, perimenopause symptom management. Each line carries its own regulatory frame, claims standard, evidence expectation, and consumer scrutiny — and consumer scrutiny in this category is high. Claims that read as supportive in one frame can read as drug claims in another. Positioning that sits comfortably as lifestyle in one channel can attract regulatory attention in the next. RGM provides senior input on where the product belongs, what it can credibly say, and what evidence the strategy actually needs.

The work draws on decades of operating experience leading regulatory, scientific, and innovation strategy across women's health and consumer healthcare. The goal is a position that is regulatorily defensible, scientifically credible, and commercially coherent — not three different stories that don't reconcile.

What's typically included

Product positioning across categories — senior read on whether a product is best positioned as a drug, device, supplement, diagnostic, or combination, and the implications of each for evidence, claims, and channel.
Claims feasibility — structured assessment of intended claims against the regulatory frame chosen, including the medical-vs-lifestyle framing question that is central to this category.
Evidence strategy — pragmatic recommendations on the evidence the product actually needs to support its positioning, claims, and consumer credibility.
Regulatory considerations — pathway, classification, labeling, and lifecycle implications specific to women's health products and the way they are marketed.
Portfolio & sequencing input — for brands developing more than one product in the category, senior input on which to lead with and how the rest sequence behind it.

When this is the right conversation

Founders and brand teams typically engage RGM here when a women's health product is being shaped and the team is deciding which regulatory frame it belongs in; when claims for a menopause, fertility, pelvic health, or hormone product need to be reconciled with the evidence on hand; when a brand is moving across categories (for example, adding a supplement to a device line, or a diagnostic to a drug line); or when investor or retailer scrutiny on claims has surfaced and the team needs a senior read on the gap.

Output you can use

A documented position on where the product fits in the U.S. regulatory landscape, what it can credibly claim, what evidence the claim set requires, and how the brand can sequence multiple products in the category without collapsing the regulatory story. Written for a leadership team, a board, or an investor without further translation.

Women's Health Regulatory & Innovation Advisory

What's typically included

When this is the right conversation

Output you can use

Building or sharpening a women's health product?

Related Services

Claims, Evidence & Scientific Credibility

Innovation & Product Development Advisory

Dietary Supplements, Consumer Health & Non-Prescription